According to an updated enforcement report from the Food and Drug Administration, 54,532 bottles of levothyroxine sodium tablets were recalled because they were sub-potent, or not as strong as ...

associate professor of pharmacology and toxicology at Michigan State University. This recall was initially issued last month, but has now been designated a Class II risk level. What does that mean, ...

Drugs to address metabolic health issues have gained mainstream awareness, but for individuals with underactive thyroid, one class of drug has been trusted for some time. This week one of those has ...

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA. Levothyroxine sodium tablet: EMD Serono has discontinued all presentations of Euthyrox ...

Every fluid and cell in our bodies contains electrolytes. Sodium, magnesium, potassium, and calcium are among the MVP electrolytes, adds Natalie Rizzo, MS, RD, plant-based sports dietitian with ...

Co announces that the FDA has granted final approval for the Company's Abbreviated New Drug Application for Rabeprazole Sodium Delayed-Release Tablets, 20 mg. TEVA's Rabeprazole Sodium Delayed-Release ...

The USAN, consisting of members from the Food and Drug Administration (FDA), American Medical Association (AMA), United States Pharmacopeia (USP) and the American Pharmacists Association (APhA), is ...